KB Medical announces that its innovative KBMED Safety Lancet Series will officially enter the U.S. market in June 2026, further expanding the company’s portfolio of advanced diabetes care and clinical safety solutions. The new product lineup includes: Push Button Activated Safety Lancet Adjustable Push Button Activated Safety Lancet Designed for safer and more efficient blood collection, the KBMED Safety Lancet Series features one-button activation, automatic needle retractio

KB Medical proudly announces the successful launch of its KBMED GDH Series Blood Glucose Monitoring Systems in the Central American market, marking a key milestone in the company’s global diabetes care expansion. Powered by advanced GDH (Glucose Dehydrogenase) technology, the KBMED GDH Series delivers accurate, stable, and fast blood glucose testing for hospitals, clinics, pharmacies, and home users. Key advantages include: High testing accuracy with reduced interference Fast

Bulgaria — April 1, 2026 — KB Medical Group (KBMED) announced that its insulin syringes continue to achieve a strong sales performance across the European market, reflecting steady demand from healthcare providers and patients. At the same time, KBMED is accelerating the expansion of its diabetes care product portfolio , with new products—including insulin pen needles , lancets , and blood glucose monitoring devices —scheduled for release in the near future. What is an Insu

Look and feel incredible with KBMED's new Safety Lancets with depth-adjustable and pressure-activated lancing. For more information on...

D iscover the superior design and functionality of KBMED's new heel incision safety lancets . F or more product information on KBMED's ...

Following KB's recent new FDA 510(k) clearance from US Food and Drug Administration (FDA) for KB's vacuum urine collection tube, we also...